Autopsy report · NCT00894790
Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident
Cause of deathNo reason given
“See termination reason in detailed description.”
Life of this trial
- Registered 8 months before it started.
- Ran for about 2 months before it stopped.
- 8 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Sponsor type
- Industry
- Conditions
- Pain
- Interventions
- Celecoxib; oral Diclofenac
- Participants
- 8
- Sites
- 2
- Countries
- Mexico
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.